含氮芥基查尔酮类衍生物的合成、晶体结构及抗肿瘤活性

doi:10.6023/cjoc201211041

有机化学 ›› 2013, Vol. 33 ›› Issue (03): 523-529.DOI: 10.6023/cjoc201211041 上一篇下一篇

研究论文

含氮芥基查尔酮类衍生物的合成、晶体结构及抗肿瘤活性

方线文, 周丽珍, 成昭, 杨美盼, 杨秉勤

西北大学化学与材料科学学院天然产物及功能分子教育部重点实验室西安 710069

收稿日期:2012-11-21 修回日期:2012-12-17 发布日期:2012-12-20
通讯作者: 杨秉勤 E-mail:yangbq@nwu.edu.cn; fxw325@126.com
基金资助:
国家自然科学基金(No. 21172178)资助项目.

Synthesis, Crystal Strutures and Antitumor Activity of Novel Nitrogen Mustard-Linked Chalcones

Fang Xianwen, Zhou Lizhen, Cheng Zhao, Yang Meipan, Yang Bingqin

Key Laboratory of Synthetic and Natural Functional Molecule Chemistry of Ministry of Education, Department of Chemistry and Materials Science, Northwest University, Xi'an 710069

Received:2012-11-21 Revised:2012-12-17 Published:2012-12-20
Supported by:
Project supported by the National Natural Science Foundation of China (No. 21172178).

文章分享

1. 含氮芥基查尔酮类衍生物的合成、晶体结构及抗肿瘤活性.PDF(271KB)

摘要/Abstract

根据拼药原理, 将氮芥类抗肿瘤药物的药效基团N,N-二(2-氯乙基)氨基拼接到查尔酮结构中, 合成出了一系列新型含氮芥基的查尔酮衍生物3a～3r, 并用¹H NMR, IR, HRMS-ESI及X射线对其结构进行了确证. 采用MTT法对所合成的化合物进行了体外抗肿瘤活性测试, 结果表明部分化合物对所选肿瘤细胞的增殖有较强的抑制作用, 其中, 化合物3j和3l对K562的IC₅₀值分别为20.01和18.6 μmol/L; 对HepG2的IC₅₀值分别为43.46和21.39 μmol/L. 实验培养并得到了目标产物3e和3l的晶体结构, X射线分析表明化合物3e和3l都属三斜晶系, P-1空间群.

A series of novel nitrogen mustard-linked chalcones 3a～3r were synthesized by linking the N,N-bis(2- chloroethyl)amine pharmacophore of nitrogen mustards to the chalcone’s framework. Their structures were characterized by ¹H NMR, IR, ESI-HRMS and X-ray techniques. The antitumor activities of the nitrogen mustard-linked chalcones were evaluated against K562 and HepG2 cell lines by an MTT assay. The results reveal that some of the title compounds exhibit potent anti-proliferative activities against selected tumor cells. Among which, compounds 3j against K562 and HepG2 with IC₅₀ values of 20.01 and 43.46 μmol/L, and 3l against K562 and HepG2 with IC₅₀ values of 18.6 and 21.39 μmol/L, respectively. Suitable crystals of 3e and 3l were obtained, and the X-ray diffraction analysis indicates that compounds 3b and 3e are both belong to triclinic, space group P-1.

Key words: chalcones, nitrogen mustard, synthesis, crystal structure, anti-tumor activity

引用此文

方线文, 周丽珍, 成昭, 杨美盼, 杨秉勤. 含氮芥基查尔酮类衍生物的合成、晶体结构及抗肿瘤活性[J]. 有机化学, 2013, 33(03): 523-529.

Fang Xianwen, Zhou Lizhen, Cheng Zhao, Yang Meipan, Yang Bingqin. Synthesis, Crystal Strutures and Antitumor Activity of Novel Nitrogen Mustard-Linked Chalcones[J]. Chin. J. Org. Chem., 2013, 33(03): 523-529.

导出引用 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

分享此文

参考文献

[1] Haraguchi, H.; Ishikawa, H.; Mizutani, K.; Tamura, Y.; Kinoshita, T. Bioorg. Med. Chem. 1998, 6, 339.

[2] Kumar, S. K.; Hager, E.; Pettit, C.; Gurulingappa, H.; Davidson, N. E.; Khan, S. R. J. Med. Chem. 2003, 46, 2813.

[3] Herencia, F.; Ferrandiz, M. L.; Ubeda, A.; Dominguez, J. N.; Charris, J. E.; Lobo, G. M.; Alcaraz, M. J. Bioorg. Med. Chem. Lett. 1998, 8, 1169.

[4] Ni, L.-M.; Meng, C.-Q.; Sikorski, J. A. Expert Opin. Ther. Pat. 2004, 14, 1669.

[5] Trivedi, J. C.; Bariwal, J. B.; Upadhyay, K. D.; Naliapara, Y. T.; Joshi, S. K.; Pannecouque, C. C.; Clercq, E. D.; Shaha, A. K. Tetrahedron Lett. 2007, 48, 8472.

[6] Nowakowska, Z.; Kedzia, B.; Schroeder, G. Eur. J. Med. Chem. 2008, 43, 707.

[7] Lopez, S. N.; Castelli, M. V.; Zacchino, S. A.; Domınguez, J. N.; Lobo, G.; Charris-Charris, C.; Cortes, J. C. G.; Ribas, J. C.; Devia, C.; Rodrıguez, A. M.; Enriz, R. D. Bioorg. Med. Chem. 2001, 9, 1999.

[8] Murakami, S.; Muramatsu, M.; Aihara, H. Biochem. Pharmacol. 1991, 42, 1447.

[9] Hseu, Y. C.; Lee, M. S.; Wu, C.-R.; Cho, H.-J.; Lin, K.-Y.; Lai, G.-H.; Wang, S.-Y.; Kuo, Y.-H.; Kumar, K. J. S.; Yang, H. L. J. Agric. Food Chem. 2012, 60, 2385.

[10] Kumar, S. K.; Hager, E.; Pettit, C.; Gurulingappa, H.; Davidson, N. E.; Khan, S. R. J. Med. Chem. 2003, 46, 2813.

[11] Lorenzo, P.; Alvarez, R.; Ortiz, M. A.; Alvarez, S.; Piedrafita, F. J.; Lera, A. R. J. Med. Chem. 2008, 51, 5431.

[12] Tatsuzaki, J.; Bastow, K. F.; Nakagawa-Goto, K.; Nakamura, S.; Itokawa, H.; Lee, K. H. J. Nat. Prod. 2006, 69, 1445.

[13] Rajski, S. R.; Williams, R. M. Chem. Rev. 1998, 98, 2723.

[14] Rink, S. M.; Hopkins, P. B. Bioorg. Med. Chem. Lett. 1995, 5, 2845.

[15] Catovsky, D.; Else, M.; Richards, S. Clin. Lymphoma, MyelomaLeuk. 2011, 11, S2.

[16] Kapoor, P.; Rajkumar, S. V.; Dispenzieri, A.; Gertz, M. A.; Lacy, M. Q.; Dingli, D.; Mikhael, J. R.; Roy, V.; Kyle, R. A.; Greipp, P. R.; Kumar, S.; Mandrekar, S. J. Leukemia 2011, 25, 689.

[17] Rappeneau, S.; Squiban, A. B.; Boucher, F. B.; Aubery, M.; Gendron, M. C.; Marano, F. Toxicol. In Vitro 1999, 13, 765.

[18] Ren, J.; Xu, H.-J.; Cheng, H.; Xin, W.-Q.; Chen, X.; Hu, K. Eur. J. Med. Chem. 2012, 54, 175.

[19] Zhuang, Y.-Y.; Zhou, C.-H.; Wang, Y.-F.; Li, D.-H. Chin. Pharm. J. 2008, 17, 1281 (in Chinese).
(庄雅云, 周成合, 王渝芳, 李东红, 中国药学杂志, 2008, 17, 1281.)

[20] Xu, F.-H.; Gan, Y.; Zhang, Y.-H.; Luo, W.; Ma, H.-X.; Wang, C.-J.; Zhao, J. Chin. J. Org. Chem. 2011, 31, 1122 (in Chinese).
(许凤华, 甘莹, 张亚宏, 罗稳, 马红霞, 王超杰, 赵瑾, 有机化学, 2011, 31, 1122.)

[21] Tang, Y.-D.; Zhang, J.-Q.; Zhang, S.-L.; Geng, R.-X.; Zhou, C.-H. Chin. J. Chem. 2012, 30, 1831.

[22] Srinivasan, B.; Johnson, T. E.; Lad, R.; Xing, C.-G. J. Med. Chem. 2009, 52, 7228.

含氮芥基查尔酮类衍生物的合成、晶体结构及抗肿瘤活性

Synthesis, Crystal Strutures and Antitumor Activity of Novel Nitrogen Mustard-Linked Chalcones

PDF

补充材料

可视化

被引次数

摘要/Abstract

引用此文

分享此文

参考文献

相关文章 0

编辑推荐

相关统计

本文评价